Source:http://linkedlifedata.com/resource/pubmed/id/19560994
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-6-29
|
pubmed:abstractText |
Metabolic syndrome (MS) is a complicated disorder associated with a high risk of future development of micro- and macrovascular complications. The extrahepatic manifestations of hepatitis C virus (HCV) infection can include multiple metabolic abnormalities. However, the extent, severity, and characteristics of MS in HCV-infected patients have rarely been investigated in community-based settings. This study aimed to determine the difference in prevalence and distribution of the components of MS between HCV-infected patients and healthy controls. Multipurpose mass screening of adults was conducted in an HCV-endemic area of Southern Taiwan. Clinical profiles in terms of anthropometric data and MS components, as well as viral hepatitis markers, were assessed. Two hundred and thirty-seven adults (94 males; mean age, 55.5 +/- 10.8 years) were recruited. The prevalence of anti-HCV seropositivity was 39.2% (93/237). The prevalence of MS was higher in the HCV-infected individuals (24.7%, 23/93) than in the control, uninfected subjects (13.2%, 19/144, p = 0.02). In terms of MS components, HCV-infected subjects had a higher prevalence of high waist circumference (51.6% vs. 25.7%, p < 0.001) and hypertension (58.1% vs. 36.8%, p = 0.001) than controls. Multivariate logistic regression analysis demonstrated that anti-HCV positivity was significantly associated with MS (odds ratio, 6.4; 95% confidence interval, 1.82-22.84; p = 0.004). HCV infection was associated with a higher prevalence of MS. Determination of MS in patients with HCV infection could therefore be indicated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1607-551X
|
pubmed:author |
pubmed-author:ChangWen-YuWY,
pubmed-author:ChenShinn-ChernSC,
pubmed-author:ChuangWan-LongWL,
pubmed-author:DaiChia-YenCY,
pubmed-author:HsiehMeng-HsuanMH,
pubmed-author:HuangChing-ICI,
pubmed-author:HuangChung-FengCF,
pubmed-author:HuangJee-FuJF,
pubmed-author:LinZu-YauZY,
pubmed-author:YangJeng-FuJF,
pubmed-author:YehMing-LunML,
pubmed-author:YuMing-LungML,
pubmed-author:YuSung-HuaSH
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
299-305
|
pubmed:meshHeading |
pubmed-meshheading:19560994-Aged,
pubmed-meshheading:19560994-Case-Control Studies,
pubmed-meshheading:19560994-Female,
pubmed-meshheading:19560994-Hepatitis C,
pubmed-meshheading:19560994-Humans,
pubmed-meshheading:19560994-Male,
pubmed-meshheading:19560994-Metabolic Syndrome X,
pubmed-meshheading:19560994-Middle Aged,
pubmed-meshheading:19560994-Multivariate Analysis,
pubmed-meshheading:19560994-Taiwan
|
pubmed:year |
2009
|
pubmed:articleTitle |
Hepatitis C virus infection and metabolic syndrome---a community-based study in an endemic area of Taiwan.
|
pubmed:affiliation |
Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, and Graduate Institute of Medicine, College of Health Science, Kaohsiung Medical University, Kaohsiung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|